https://www.ophthalmologytimes.com/view/retinai-discovery-from-ikerian-receives-class-iia-mdr-registration-in-eu 2024-06-24 0.50 https://www.ophthalmologytimes.com/view/artificial-intelligence-patient-resource-findings-from-a-chatbot-investigation 2024-06-21 0.50 https://www.ophthalmologytimes.com/view/aurion-biotech-candidate-aurn001-receives-us-breakthrough-therapy-designation-and-regenerative-medicine-advanced-therapy-designation 2024-06-21 0.50 https://www.ophthalmologytimes.com/view/the-36th-annual-international-congress-of-german-ophthalmic-surgery-doc-comes-to-nuremberg 2024-06-18 0.50 https://www.ophthalmologytimes.com/view/beacon-therapeutics-treats-first-patient-in-global-registration-trial-for-x-linked-retinitis-pigmentosa-therapeutic 2024-06-17 0.50 https://www.ophthalmologytimes.com/view/paediatric-case-study-suggests-genetic-syndrome-link-associated-with-ocular-tumor 2024-06-14 0.50 https://www.ophthalmologytimes.com/view/combining-imaging-modalities-for-early-identification-of-diabetic-retinopathy 2024-06-13 0.50 https://www.ophthalmologytimes.com/view/why-imaging-is-key-to-managing-geographic-atrophy 2024-06-13 0.50 https://www.ophthalmologytimes.com/view/nidek-announces-ce-mark-for-iol-injector-launch-of-new-oct-device 2024-06-12 0.50 https://www.ophthalmologytimes.com/view/metabolomics-and-the-molecular-approach-to-glaucoma-diagnosis 2024-06-11 0.50 https://www.ophthalmologytimes.com/view/new-therapeutic-targets-drug-development-for-retinitis-pigmentosa 2024-06-11 0.50 https://www.ophthalmologytimes.com/view/recap-the-association-for-research-in-vision-and-ophthalmology-takes-seattle 2024-06-07 0.50 https://www.ophthalmologytimes.com/view/factors-affecting-rop-development-in-first-8-weeks-after-birth 2024-06-07 0.50 https://www.ophthalmologytimes.com/view/risk-factors-for-retinal-detachment-in-marfan-syndrome-after-paediatric-lens-removal 2024-06-06 0.50 https://www.ophthalmologytimes.com/view/a-safe-and-effective-non-ablative-treatment-with-multiple-applications-for-the-ocular-surface 2024-06-05 0.50 https://www.ophthalmologytimes.com/view/topical-drop-treatment-for-full-thickness-macular-hole-closure 2024-06-05 0.50 https://www.ophthalmologytimes.com/view/safety-and-efficacy-findings-from-the-xen45-glaucoma-implant 2024-06-04 0.50 https://www.ophthalmologytimes.com/view/slt-delivery-by-non-medical-ophthalmic-practitioners-could-serve-patients-with-glaucoma 2024-06-03 0.50 https://www.ophthalmologytimes.com/view/espansione-group-receives-ce-mark-approval-for-eye-light-photobiomodulation-device 2024-06-04 0.50 https://www.ophthalmologytimes.com/view/is-artificial-intelligence-ai-the-solution-to-saving-ophthalmologists-time- 2024-06-03 0.50 https://www.ophthalmologytimes.com/view/global-leaders-in-cataract-run-the-olympic-gauntlet-of-surgery 2024-06-03 0.50 https://www.ophthalmologytimes.com/view/the-16th-european-glaucoma-society-congress-is-underway-in-dublin 2024-05-31 0.50 https://www.ophthalmologytimes.com/view/monitoring-glaucoma-progression-rate-to-preserve-patients-vision 2024-05-30 0.50 https://www.ophthalmologytimes.com/view/european-commission-grants-marketing-authorisation-for-bevacizumab-gamma 2024-05-29 0.50 https://www.ophthalmologytimes.com/view/dopavision-announces-topline-results-for-myopiax-trial-for-slowing-paedatric-myopia-progression 2024-05-29 0.50 https://www.ophthalmologytimes.com/view/racing-against-microbial-keratitis-paediatric-ocular-eye-injury 2024-05-28 0.50 https://www.ophthalmologytimes.com/view/role-of-ferroptosis-in-bacterial-keratitis 2024-05-27 0.50 https://www.ophthalmologytimes.com/view/post-hoc-analysis-shows-how-pegcetacoplan-may-impact-rpe-atrophy 2024-05-24 0.50 https://www.ophthalmologytimes.com/view/part-4-improving-surgical-performance-with-an-ai-based-application 2024-05-23 0.50 https://www.ophthalmologytimes.com/view/part-3-optimizing-outcome-precision-with-leading-edge-advanced-lens-technology 2024-05-23 0.50 https://www.ophthalmologytimes.com/view/part-2-the-digital-operating-room 2024-05-23 0.50 https://www.ophthalmologytimes.com/view/part-1-streamlining-the-cataract-workflow-from-preoperative-assessment-to-post-surgery 2024-05-23 0.50 https://www.ophthalmologytimes.com/view/professor-noemi-lois-awarded-edinburgh-king-james-iv-professorship-retina-royal-college-of-surgeons 2024-05-22 0.50 https://www.ophthalmologytimes.com/view/united-states-fda-approves-two-aflibercept-2-mg-biosimilars-opuviz-yesafili 2024-05-21 0.50 https://www.ophthalmologytimes.com/view/predicting-visual-acuity-with-a-machine-learning-system 2024-05-21 0.50 https://www.ophthalmologytimes.com/view/the-evolving-role-of-vitreosurgical-simulators-in-surgical-training-virtual-reality 2024-05-20 0.50 https://www.ophthalmologytimes.com/view/for-younger-patients-with-mid-range-myopia-consider-phakic-iols 2024-05-17 0.50 https://www.ophthalmologytimes.com/view/the-good-the-bad-and-the-maybe-in-ocular-gene-therapies 2024-05-15 0.50 https://www.ophthalmologytimes.com/view/outlook-therapeutics-submits-uk-marketing-authorisation-application-for-wet-amd-treatment 2024-05-13 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-trial-design-and-increased-accuracy-of-meibomian-gland-morphology-measurements 2024-05-09 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-mutation-agnostic-optogenetic-programme-demonstrates-possible-treatment-for-patients-with-severe-retinal-degeneration 2024-05-09 0.50 https://www.ophthalmologytimes.com/view/going-beyond-the-clinical-setting-in-ophthalmic-mentorship 2024-05-10 0.50 https://www.ophthalmologytimes.com/view/keratometry-and-total-keratometry-values-are-similar-in-healthy-eyes-astigmatism 2024-05-08 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-predicting-the-efficacy-of-myopia-control-methods-using-1-year-data 2024-05-08 0.50 https://www.ophthalmologytimes.com/view/reconfiguring-treatment-goals-for-paediatric-myopia-around-ocular-development 2024-05-08 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-president-elect-srinivas-sadda-md-shares-his-strategies-for-engaging-vision-experts-worldwide 2024-05-08 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-reliability-of-contact-specular-microscopy-in-the-corneal-endothelium 2024-05-07 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-non-invasive-testing-could-use-tear-film-to-screen-for-huntington-disease 2024-05-07 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-exploring-multi-ingredient-oral-supplements-for-alleviating-symptoms-of-dry-eye-disease 2024-05-07 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-evaluating-a-lipid-containing-eye-drop-for-dry-eye-disease-novel-clinical 2024-05-07 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-dry-eye-patient-selection-following-post-hoc-analysis-of-gobi-and-mojave-trials 2024-05-07 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-assessing-melanocortin-receptors-and-inflammation-in-the-ocular-space 2024-05-07 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-imaging-provides-insights-to-the-metabolic-aspects-of-glaucoma-development 2024-05-07 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-children-with-cvi-experience-lower-vision-specific-quality-of-life-study-results-indicate 2024-05-06 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-novel-contact-lens-solution-bolsters-comfort-in-potential-lens-wear-dropouts 2024-05-02 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-functional-microperimetric-correlates-of-oct-structural-features-in-amd 2024-05-06 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-new-data-on-diabetic-retinopathy-lesions-from-the-drcr-retina-network 2024-05-06 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-baruch-kuppermann-md-phd-discusses-durability-of-a-pan-vegf-tyrosine-kinase-inhibitor 2024-05-06 0.50 https://www.ophthalmologytimes.com/view/efficacy-and-safety-of-aflibercept-8-mg-in-photon-trial-in-dmo 2024-05-06 0.50 https://www.ophthalmologytimes.com/view/efficacy-and-safety-of-aflibercept-8-mg-in-pulsar-trial-in-neovascular-amd 2024-05-06 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-an-adaptable-deep-learning-model-for-geographic-atrophy-segmentation 2024-05-06 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-insights-on-dry-amd-and-geographic-atrophy-from-the-gale-study-of-pegcetacoplan 2024-05-06 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-diabetic-retinopathy-risk-factors-in-paediatric-patients-with-type-1-diabetes 2024-05-05 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-champ-phase-3-trial-shows-myopia-controlled-by-low-dose-atropine-0-01-over-4-year-course 2024-05-05 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-taking-stock-of-patients-namd-experience-using-an-activity-inventory 2024-05-05 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-using-objective-measures-to-gauge-activity-levels-of-visually-impaired-children 2024-05-05 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-new-research-indicates-the-need-for-a-new-approach-to-central-vision-loss 2024-05-05 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-updates-from-the-blink2-study-on-contact-lens-wear-and-axial-length-growth 2024-05-05 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-how-delayed-onset-of-vision-impairment-alters-auditory-distance-estimation 2024-05-05 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-murine-model-of-multiple-sclerosis-demonstrates-correlation-between-visual-markers-and-motor-sensory-deficits 2024-05-05 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-dr-richard-lindstrom-encourages-ophthalmologists-of-all-ages-to-get-involved-with-yes 2024-05-03 0.50 https://www.ophthalmologytimes.com/view/arvo-2024-company-updates-and-new-clinical-data-from-the-eyecare-industry 2024-05-02 0.50 https://www.ophthalmologytimes.com/view/plan-your-visit-to-seattle-this-year-s-arvo-meeting-promises-must-see-programming 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/espansione-group-illuminating-the-future-of-amd-treatment-the-breakthrough-of-lightwave-i-trial-with-pbm-technology 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/data-from-self-tonometry-supports-glaucoma-treatment-decisions 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-2---change-for-success-example 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-3---esrs-clinical-trends-survey-results 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-1---barret-toric-calculator 2024-05-03 0.50 https://www.ophthalmologytimes.com/view/part-4---what-do-i-get-cause-of-complications 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-2---change-for-success 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-1---streamlining-the-workflow 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-3---work-smart-not-hard-conclusion 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-2---catarat-surgery-example 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-4---what-is-the-surgery-optimizer 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-2---the-missing-piece-of-full-connected-puzzle 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-1---postoperative-optimization-what-to-think-of- 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-4---what-do-i-get-comparison-of-surgeries 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-2---data-recovery-in-the-operating-room 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-1---posterior-surface-of-the-cornea 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-3---conclusion 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-3---work-smart-not-hard-case-2 2024-05-01 0.50 https://www.ophthalmologytimes.com/view/part-1---digital-medical-networking-structure-connecting-diagnostics 2024-04-30 0.50 https://www.ophthalmologytimes.com/view/may-is-inherited-retinal-disease-genetic-testing-awareness-month-prevent-blindness-expands-on-previous-weeklong-campaign 2024-05-08 0.50 https://www.ophthalmologytimes.com/view/tease-3-study-positive-interim-data-are-reported-for-stargardt-drug 2024-04-25 0.50 https://www.ophthalmologytimes.com/view/interactive-vision-simulator-illustrates-the-vision-loss-caused-by-retinal-diseases 2024-04-25 0.50 https://www.ophthalmologytimes.com/view/retina-community-mourns-sudden-loss-of-ramin-tadayoni-md-phd-euretina-death-obituary 2024-04-22 0.50 https://www.ophthalmologytimes.com/view/amniotic-membrane-could-move-the-needle-outside-of-the-operating-room-nuvision 2024-04-19 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-migs-data-is-outpacing-human-intelligence-driving-calls-for-ai 2024-04-18 0.50 https://www.ophthalmologytimes.com/view/clinicians-and-researchers-don-t-shy-away-from-hot-topics-in-the-field 2024-04-18 0.50 https://www.ophthalmologytimes.com/view/selecting-the-right-patients-for-anti-vegf-biosimilar-therapy 2024-04-18 0.50 https://www.ophthalmologytimes.com/view/impact-of-biosimilars-on-the-healthcare-system 2024-04-18 0.50 https://www.ophthalmologytimes.com/view/key-clinical-findings-on-the-efficacy-safety-profile-and-immunogenicity-of-biosimilar-sb11 2024-04-18 0.50 https://www.ophthalmologytimes.com/view/review-of-the-phase-iii-clinical-trial-for-biosimilar-sb11 2024-04-18 0.50 https://www.ophthalmologytimes.com/view/biosimilar-approval-process-by-regulatory-bodies 2024-04-18 0.50 https://www.ophthalmologytimes.com/view/overview-of-biosimilars 2024-04-18 0.50 https://www.ophthalmologytimes.com/view/need-for-awareness-about-biosimilars 2024-04-18 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-real-world-results-with-an-enhanced-monovision-toric-lens 2024-04-17 0.50 https://www.ophthalmologytimes.com/view/schwind-appoints-new-head-of-global-marketing-solutions 2024-04-17 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-first-in-human-data-from-centricity-vision-s-zeptolink-iol-positioning-system 2024-04-17 0.50 https://www.ophthalmologytimes.com/view/i-screen-project-will-use-ai-and-oct-imaging-to-identify-and-monitor-amd 2024-04-23 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-two-papers-demonstrate-medication-burden-reduction-and-safety-of-a-microcatheter-for-glaucoma 2024-04-16 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-a-case-report-on-human-corneal-endothelial-cell-transplantation-combined-with-cataract-extraction-and-pciol 2024-04-15 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-a-retrospective-study-shows-istent-s-impact-on-medication-burden-in-surgical-and-non-surgical-patient-groups 2024-04-15 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-pearls-of-clinical-and-non-clinical-wisdom-for-young-eye-surgeons 2024-04-12 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-small-aperture-iols-binocularity-and-stereoacuity-in-modern-monovision 2024-04-12 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-what-advancements-in-light-adjustable-lens-technology-mean-for-clinicians-and-patients 2024-04-10 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-international-data-are-forthcoming-in-corneal-endothelial-disease-treatment 2024-04-10 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-comparing-keratometry-and-total-keratometry-values-in-a-large-dataset 2024-04-09 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-what-s-new-in-the-escrs-iol-calculator- 2024-04-09 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-at-eyecelerator-a-new-zealand-based-startup-pitches-eye-drops-for-keratoconus 2024-04-08 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-surgical-and-pharmaceutical-technology-updates-from-bausch-lomb 2024-04-08 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-ease-of-opening-arcuate-incisions-created-with-a-dual-pulse-femtosecond-laser 2024-04-07 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-10-year-results-from-a-real-world-study-shed-new-light-on-glaucoma 2024-04-07 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-ultra-low-cylinder-powered-toric-versus-non-toric-lenses-in-cataract-surgery 2024-04-06 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-enrollment-begins-in-canada-for-cell-therapy-trial-targeting-corneal-endothelial-disease 2024-04-06 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-key-features-of-lasik-using-an-updated-laser-ablation-algorithm-for-myopia-and-myopic-astigmatism 2024-04-06 0.50 https://www.ophthalmologytimes.com/view/cataract-surgery-pre-treatment-zeiss-miloop-shorter-lensectomy-time-less-irrigation-needed 2024-04-05 0.50 https://www.ophthalmologytimes.com/view/escrs-president-filomena-ribeiro-invites-ascrs-attendees-to-cataract-olympiad-after-successful-refractive-day 2024-04-05 0.50 https://www.ophthalmologytimes.com/view/ascrs-2024-cofi-integrates-with-carecredit-and-marks-participation-milestone-for-ophthalmologists-and-optometrists 2024-04-05 0.50 https://www.ophthalmologytimes.com/view/ascrs-update-new-phase-iii-study-results-and-near-future-plans-for-nt-501 2024-04-06 0.50 https://www.ophthalmologytimes.com/view/to-infinity-and-pres-byond---the-game-changer-for-my-practice 2025-06-05 0.50 https://www.ophthalmologytimes.com/view/carl-zeiss-meditec-ag-announces-completed-acquisition-of-dutch-ophthalmic-research-center 2024-04-04 0.50 https://www.ophthalmologytimes.com/view/use-of-ai-to-redirect-school-aged-children-during-screen-time 2024-04-03 0.50 https://www.ophthalmologytimes.com/view/evaluation-of-an-enhanced-monofocal-intraocular-lens 2024-04-03 0.50 https://www.ophthalmologytimes.com/view/hemorrhagic-unilateral-retinopathy-no-proven-aetiology-for-rare-condition 2024-04-02 0.50 https://www.ophthalmologytimes.com/view/espansione-group-pioneering-light-based-solutions-in-ophthalmology 2024-03-26 0.50 https://www.ophthalmologytimes.com/view/arxvision-seeing-ai-navilens-announce-partnership-for-headset-programme 2024-03-29 0.50 https://www.ophthalmologytimes.com/view/women-in-ophthalmology-series-ms-neeru-a-vallabh-gives-advice-for-finding-multiple-mentors 2024-03-29 0.50 https://www.ophthalmologytimes.com/view/increase-in-the-incidence-rate-of-conjunctival-melanoma-in-australia 2024-03-28 0.50 https://www.ophthalmologytimes.com/view/global-partnership-targets-rop-in-premature-infants 2024-03-28 0.50 https://www.ophthalmologytimes.com/view/exonate-shares-results-from-phase-ib-iia-trial-of-exn407-eye-drops-for-dr-and-dme 2024-03-27 0.50 https://www.ophthalmologytimes.com/view/genetic-editing-untangles-one-strand-of-the-amd-web-crispr-cas 2024-03-26 0.50 https://www.ophthalmologytimes.com/view/outlook-therapeutics-receives-positive-chmp-opinion-for-bevacizumab-for-wet-age-related-macular-degeneration 2024-03-22 0.50 https://www.ophthalmologytimes.com/view/an-alternative-approach-to-spectacle-independence 2024-03-21 0.50 https://www.ophthalmologytimes.com/view/onboarding-a-new-trifocal-hydrophobic-c-loop-iol-my-early-experiences-with-at-elana-841p-from-zeiss 2025-02-03 0.50 https://www.ophthalmologytimes.com/view/how-amyloid-beta-peptide-and-tau-protein-demonstrate-degeneration-glaucoma-alzheimer 2024-03-21 0.50 https://www.ophthalmologytimes.com/view/focusing-on-functional-vision-with-monofocal-lenses-irof-iol 2024-03-20 0.50 https://www.ophthalmologytimes.com/view/assessing-long-term-impact-of-ocular-injuries-after-motor-vehicle-accidents 2024-03-18 0.50 https://www.ophthalmologytimes.com/view/cophy-2024-must-all-idiopathic-intracranial-hypertension-patients-get-a-spinal-tap- 2024-03-16 0.50 https://www.ophthalmologytimes.com/view/cophy-2024-should-all-elderly-patients-with-acute-visual-loss-go-to-the-emergency-department- 2024-03-16 0.50 https://www.ophthalmologytimes.com/view/intraocular-inflammation-a-major-risk-factor-resulting-from-use-of-anti-complement-agents-for-ga 2024-03-22 0.50 https://www.ophthalmologytimes.com/view/cophy-2024-is-artificial-intelligence-ready-to-replace-physicians- 2024-03-15 0.50 https://www.ophthalmologytimes.com/view/cophy-2024-how-good-are-we-really-without-artificial-intelligence-tools- 2024-03-15 0.50 https://www.ophthalmologytimes.com/view/smokers-more-likely-to-experience-vision-loss 2024-03-13 0.50 https://www.ophthalmologytimes.com/view/kiora-publishes-results-from-phase-1-study-demonstrating-safety-tolerability-and-efficacy-of-kio-101 2024-03-08 0.50 https://www.ophthalmologytimes.com/view/children-with-amblyopia-have-increased-risk-of-serious-diseases-as-adults 2024-03-07 0.50 https://www.ophthalmologytimes.com/view/women-in-ophthalmology-series-dr-alexandra-miere-encourages-young-ophthalmologists-to-step-out-of-the-comfort-zone 2024-03-18 0.50 https://www.ophthalmologytimes.com/view/women-in-ophthalmology-series-dr-filomena-ribeiro-on-the-importance-of-equity-in-education 2024-03-06 0.50 https://www.ophthalmologytimes.com/view/surgical-taming-of-neurotrophic-keratopathy-from-amniotic-membrane-grafting-to-neurotisation 2024-03-05 0.50 https://www.ophthalmologytimes.com/view/united-states-fda-approves-clobetasol-propionate-ophthalmic-suspension-0-05-from-formosa-pharmaceuticals-and-aimmax-therapeutics 2024-03-05 0.50 https://www.ophthalmologytimes.com/view/the-fourth-dimension-of-home-monitoring 2024-03-05 0.50 https://www.ophthalmologytimes.com/view/where-women-stand-a-progress-report-on-gender-equity-in-ophthalmology 2024-03-01 0.50 https://www.ophthalmologytimes.com/view/an-ophthalmologist-with-personal-experience-has-explored-the-impact-of-ai-driven-solutions 2024-02-29 0.50 https://www.ophthalmologytimes.com/view/ai-models-used-to-automate-remote-screening-for-diabetic-retinopathy 2024-02-29 0.50 https://www.ophthalmologytimes.com/view/rescuing-failed-penetrating-keratoplasty-grafts 2024-02-29 0.50 https://www.ophthalmologytimes.com/view/oct-retinal-scans-show-the-eye-kidney-connection 2024-02-22 0.50 https://www.ophthalmologytimes.com/view/translocated-gut-bacteria-possible-cause-of-some-inherited-eye-diseases-retina-blindness-gene 2024-02-26 0.50 https://www.ophthalmologytimes.com/view/prevent-blindness-launches-rop-awareness-week-with-rop-education-and-support-program 2024-02-23 0.50 https://www.ophthalmologytimes.com/view/promising-avenues-could-simplify-glaucoma-management-just-in-time 2024-03-11 0.50 https://www.ophthalmologytimes.com/view/orthok-lenses-possible-long-term-axial-length-shortening-for-myopic-patients 2024-02-21 0.50 https://www.ophthalmologytimes.com/view/researchers-present-new-monitoring-option-for-intermediate-uveitis 2024-02-20 0.50 https://www.ophthalmologytimes.com/view/sight-sciences-announces-european-launch-of-omni-surgical-system-ergo-series 2024-02-15 0.50 https://www.ophthalmologytimes.com/view/listening-to-the-heart-lessons-from-cardiology-in-remote-monitoring-and-ai 2024-02-13 0.50 https://www.ophthalmologytimes.com/view/beacon-therapeutics-12-month-data-from-phase-2-skyline-trial-of-agtc-501-for-patients-with-xlrp-retinitis-pigmentosa 2024-02-12 0.50 https://www.ophthalmologytimes.com/view/us-fda-grants-okyo-pharma-ind-approval-for-neuropathic-corneal-pain-therapy-ok-101 2024-02-09 0.50 https://www.ophthalmologytimes.com/view/optica-spiral-diopter-lens-multifocal-vision-correction-contact-intraocular-implant 2024-02-09 0.50 https://www.ophthalmologytimes.com/view/iridex-corporation-receives-european-patent-on-micropulse-technology 2024-02-06 0.50 https://www.ophthalmologytimes.com/view/ucl-and-moorfields-eye-hospital-receive-5-million-toward-eye-health-research-facility-oriel 2024-02-05 0.50 https://www.ophthalmologytimes.com/view/toku-obtains-ce-and-ukca-marks-for-ai-cardiovascular-risk-assessments-through-the-eye 2024-02-05 0.50 https://www.ophthalmologytimes.com/view/extracellular-vesicles-could-be-the-future-of-retinal-diseases 2024-02-02 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2024-interim-findings-of-phase-2-ripple-1-trial-on-intravitreal-dexamethasone-implant-for-dmo-and-rvo 2024-02-02 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2024-highlighting-72-week-results-from-the-balaton-and-comino-phase-3-studies-of-faricimab-in-retinal-vein-oclusion 2024-02-02 0.50 https://www.ophthalmologytimes.com/view/voyager-study-provides-data-on-real-world-effectiveness-of-faricimab-for-namd-and-dme 2024-02-01 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2024-targeting-ang2-and-vegf-biology-pharmacokinetics-and-latest-clinical-data-in-namd-and-dme 2024-01-31 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2024-the-implication-of-longitudinal-ai-based-fluid-quantification-for-at-home-monitoring 2024-02-01 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2024-findings-from-the-davio-2-trial-assessing-eyp-1901-vs-aflibercept-for-wet-amd 2024-01-31 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2024-expanded-efficacy-data-from-the-gather-2-trial 2024-02-01 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2024-distinguishing-aspects-of-early-onset-amd-netherlands 2024-02-01 0.50 https://www.ophthalmologytimes.com/view/multimodal-assessment-of-oct-adds-perspective-on-ga-and-amd-progression 2024-02-01 0.50 https://www.ophthalmologytimes.com/view/kiora-pharmaceuticals-and-th-a-open-innovation-announce-partnership 2024-02-01 0.50 https://www.ophthalmologytimes.com/view/case-report-diversifying-cataract-outcomes-yag-laser 2024-02-02 0.50 https://www.ophthalmologytimes.com/view/ai-ocular-screenings-facilitate-early-intervention-for-paediatric-patients 2024-01-31 0.50 https://www.ophthalmologytimes.com/view/biosimilars-expand-treatment-options-patients-retinal-disease 2024-05-09 0.50 https://www.ophthalmologytimes.com/view/what-do-you-do-when-there-is-no-cataract-standalone-glaucoma 2024-01-29 0.50 https://www.ophthalmologytimes.com/view/plan-your-afternoon-sessions-at-the-angiogenesis-exudation-and-degeneration-2024-conference 2024-01-26 0.50 https://www.ophthalmologytimes.com/view/2024-angiogenesis-exudation-and-degeneration-conference-a-1-day-virtual-symposium-of-all-things-retina 2024-01-26 0.50 https://www.ophthalmologytimes.com/view/iridex-and-imperial-college-healthcare-nhs-trust-announce-collaborative-micropulse-tlt-study 2024-01-24 0.50 https://www.ophthalmologytimes.com/view/corneas-harvested-from-drowning-victims-are-viable-for-transplantation 2024-01-24 0.50 https://www.ophthalmologytimes.com/view/intra-anterior-chamber-anti-vegf-injections-feasible-treatment-for-advanced-paediatric-vitreoretinal-diseases 2024-01-23 0.50 https://www.ophthalmologytimes.com/view/potential-for-achieving-broader-range-of-vision-with-a-monofocal-iol-preliminary-findings-in-patients-implanted-with-the-zeiss-ct-lucia-621p-iol 2024-01-31 0.50 https://www.ophthalmologytimes.com/view/nei-shares-outcomes-from-workshop-on-cerebral-cortical-visual-impairment 2024-01-22 0.50 https://www.ophthalmologytimes.com/view/disease-management-and-data-integration-zeiss-meditec-looks-ahead-following-dutch-ophthalmic-research-center-announcement 2024-01-18 0.50 https://www.ophthalmologytimes.com/view/morrow-and-novacel-optical-partner-ahead-of-eprogressive-smart-glasses-distribution 2024-01-17 0.50 https://www.ophthalmologytimes.com/view/rayner-announces-acquisition-of-swiss-ophthalmology-innovation-and-sophi-phaco-technology 2024-01-17 0.50 https://www.ophthalmologytimes.com/view/pupillometry-responses-may-serve-as-biomarkers-for-depression-provide-treatment-indications 2024-01-16 0.50 https://www.ophthalmologytimes.com/view/aao-welcomes-president-jane-c-edmond-md-to-2024-term 2024-01-15 0.50 https://www.ophthalmologytimes.com/view/annexon-outlines-anx007-global-pivotal-programme-for-geographic-atrophy-beginning-mid-2024 2024-01-12 0.50 https://www.ophthalmologytimes.com/view/gentex-acquires-esight-ahead-of-ces-2024 2024-01-11 0.50 https://www.ophthalmologytimes.com/view/uk-ophthalmology-students-report-impact-of-covid-19-on-clinical-education 2024-01-08 0.50 https://www.ophthalmologytimes.com/view/european-commission-grants-eu-marketing-authorisation-for-aflibercept-eylea-8-mg 2024-01-08 0.50 https://www.ophthalmologytimes.com/view/prevent-blindness-marks-glaucoma-awareness-month-with-free-educational-resources-glaucoma-toolkit 2024-01-05 0.50 https://www.ophthalmologytimes.com/view/new-report-alvotech-announces-positive-top-line-results-for-avt06-a-proposed-biosimilar-to-aflibercept 2024-01-04 0.50 https://www.ophthalmologytimes.com/view/the-year-in-eye-care-5-top-stories-from-modern-retina-in-2023 2023-12-21 0.50 https://www.ophthalmologytimes.com/view/the-year-in-eye-care-ophthalmology-times-presents-its-2023-wrapped 2024-01-02 0.50 https://www.ophthalmologytimes.com/view/the-year-in-eye-care-top-5-optometry-stories-from-2023 2023-12-21 0.50 https://www.ophthalmologytimes.com/view/looking-back-looking-forward-top-stories-from-ophthalmology-times-europe-2023 2024-12-16 0.50 https://www.ophthalmologytimes.com/view/faricimab-for-namd-and-dme-welcome-to-the-real-world 2023-12-18 0.50 https://www.ophthalmologytimes.com/view/the-case-for-ultrawidefield-guided-swept-source-oct 2023-12-18 0.50 https://www.ophthalmologytimes.com/view/new-migs-devices-aid-patients-and-test-patience 2023-12-18 0.50 https://www.ophthalmologytimes.com/view/cannabis-use-carries-no-risk-of-primary-open-angle-glaucoma 2023-12-15 0.50 https://www.ophthalmologytimes.com/view/cross-linking-in-paediatric-patients-the-case-for-treating-keratoconus-without-waiting-for-disease-progression 2023-12-14 0.50 https://www.ophthalmologytimes.com/view/next-gen-lasers-and-iols-for-every-patient-the-year-ahead-in-cornea 2023-12-13 0.50 https://www.ophthalmologytimes.com/view/exonate-s-lead-ophthalmology-candidate-exn407-meets-endpoints-in-phase-ib-iia-trial-for-diabetic-macular-oedema 2023-12-12 0.50 https://www.ophthalmologytimes.com/view/research-results-olix-pharmaceuticals-announces-positive-results-of-phase-1-safety-and-tolerability-results-of-olx10212-for-amd 2023-12-12 0.50 https://www.ophthalmologytimes.com/view/in-2024-data-driven-tools-will-shape-cataract-and-refractive-surgery 2023-12-11 0.50 https://www.ophthalmologytimes.com/view/virtual-simulations-improve-global-surgical-outcomes 2023-12-08 0.50 https://www.ophthalmologytimes.com/view/recap-aao-2023-brings-data-diagnostics-and-digital-workflows-to-the-forefront 2023-12-07 0.50 https://www.ophthalmologytimes.com/view/collaborative-rheumatologic-ophthalmologic-teams-could-improve-management-of-patients-with-rheumatic-diseases 2023-12-06 0.50 https://www.ophthalmologytimes.com/view/why-the-future-of-ophthalmology-is-in-corneal-grafts-modern-keratoplasty-alio-book 2023-12-05 0.50 https://www.ophthalmologytimes.com/view/new-research-data-reflect-patient-satisfaction-following-faricimab-treat-and-extend-regimen 2023-12-05 0.50 https://www.ophthalmologytimes.com/view/today-prevent-blindness-participates-in-first-ever-world-geographic-atrophy-day-december-5 2023-12-04 0.50 https://www.ophthalmologytimes.com/view/how-to-smile-with-a-challenging-patient-reaping-the-speed-of-the-visumax-800-femtosecond-laser 2023-12-04 0.50 https://www.ophthalmologytimes.com/view/a-global-view-of-diabetic-eye-disease 2023-12-01 0.50 https://www.ophthalmologytimes.com/view/cellular-evidence-of-retinal-ganglion-cell-transfection-after-lhon-treatment 2023-11-30 0.50 https://www.ophthalmologytimes.com/view/retinsight-and-heidelberg-engineering-partner-to-implement-ai-based-geographic-atrophy-analysis-for-oct-imaging 2023-11-30 0.50 https://www.ophthalmologytimes.com/view/escrs-presenters-and-attendees-give-advice-to-young-ophthalmologists-and-their-past-selves 2023-12-01 0.50 https://www.ophthalmologytimes.com/view/mhra-issues-safety-recall-for-dry-eye-gel-treatments 2023-11-28 0.50 https://www.ophthalmologytimes.com/view/novel-3d-printed-device-may-offer-a-new-method-to-test-pharmaceuticals 2023-11-28 0.50 https://www.ophthalmologytimes.com/view/aao-2023-company-updates-from-centricity-vision-ceo-rob-thornhill 2023-11-28 0.50 https://www.ophthalmologytimes.com/view/harnessing-digital-media-for-enhanced-patient-engagement-and-outcomes 2023-11-21 0.50 https://www.ophthalmologytimes.com/view/aao-2023-marco-a-zarbin-md-provides-analysis-of-the-yosemite-and-rhine-clinical-trials 2023-11-21 0.50 https://www.ophthalmologytimes.com/view/aao-2023-results-of-the-photon-study-of-aflibercept-at-96-weeks 2023-11-20 0.50 https://www.ophthalmologytimes.com/view/disease-activity-criteria-shapes-dosing-interval-outcomes-in-clinical-trials 2023-11-20 0.50 https://www.ophthalmologytimes.com/view/aao-2023-small-aperture-iol-implantation-and-retinal-visualisation 2023-11-20 0.50 https://www.ophthalmologytimes.com/view/oxurion-nv-will-file-for-bankruptcy-following-kalahari-data-release 2023-11-20 0.50 https://www.ophthalmologytimes.com/view/the-next-frontier-in-cell-therapy-an-ethically-responsible-management-model 2023-11-17 0.50 https://www.ophthalmologytimes.com/view/former-nhs-secretary-found-guilty-of-illegally-accessing-medical-records 2023-11-17 0.50 https://www.ophthalmologytimes.com/view/new-shape-for-an-old-device-a-punctal-plug-that-better-fits-into-the-punctum 2023-11-16 0.50 https://www.ophthalmologytimes.com/view/the-future-is-now-innovations-in-vitreoretinal-surgery-3d-viewing-systems-and-robotics 2023-12-08 0.50 https://www.ophthalmologytimes.com/view/horizons-in-fundus-imaging-enhancing-reliability-quality-and-workflow-efficiency-with-the-nw500-non-mydriatic-retinal-camera 2024-01-11 0.50 https://www.ophthalmologytimes.com/view/aao-2023-new-results-from-armor-study-shed-light-on-ocular-infections 2023-11-13 0.50 https://www.ophthalmologytimes.com/view/mhra-issues-uk-approval-for-biocon-biologics-biosimilar-aflibercept-yesafili- 2023-11-13 0.50 https://www.ophthalmologytimes.com/view/ema-recommends-approval-of-high-dose-intravitreal-aflibercept-eylea-8mg-for-namd-and-macular-oedema 2023-11-13 0.50 https://www.ophthalmologytimes.com/view/aao-2023-shore-and-coast-clinical-trial-updates-from-opthea-limited 2023-11-10 0.50 https://www.ophthalmologytimes.com/view/aao-2023-how-neurotech-s-encapsulated-cell-therapy-nt-501-targets-ocular-disease 2023-11-10 0.50 https://www.ophthalmologytimes.com/view/successful-treatment-of-bilateral-diffuse-uveal-melanocytic-proliferation-with-plasmapheresis 2023-11-08 0.50 https://www.ophthalmologytimes.com/view/aao-2023-paul-runge-and-his-rop-treatments-in-the-ukraine 2023-11-08 0.50 https://www.ophthalmologytimes.com/view/aao-2023-three-technologies-from-this-year-s-new-launches-at-bausch-lomb 2023-11-08 0.50 https://www.ophthalmologytimes.com/view/capsulotomy-creation-equally-safe-using-the-manual-or-energy-based-method 2023-11-08 0.50 https://www.ophthalmologytimes.com/view/aao-2023-visus-therapeutics-presents-pivotal-brio-i-studies-for-presbyopia 2023-11-07 0.50 https://www.ophthalmologytimes.com/view/study-sight-loss-in-working-age-people-is-under-researched 2023-11-07 0.50 https://www.ophthalmologytimes.com/view/aao-2023-paediatric-myopia-management-is-focal-point-for-phase-iii-champ-and-other-trials 2023-11-06 0.50 https://www.ophthalmologytimes.com/view/first-post-mortem-study-of-human-eyes-injected-with-aav2-based-gene-therapy-for-lhon 2023-11-03 0.50 https://www.ophthalmologytimes.com/view/aao-2023-ai-chatbots-produce-inaccurate-responses-for-eye-health-information 2023-11-06 0.50 https://www.ophthalmologytimes.com/view/aao-2023-advancements-in-dry-age-related-macular-degeneration-treatment 2023-10-30 0.50 https://www.ophthalmologytimes.com/view/aao-2023-visual-field-defects-linked-to-risk-of-vehicular-accidents-in-aging-population 2023-11-06 0.50 https://www.ophthalmologytimes.com/view/learnings-from-real-world-evidence-of-faricimab-in-namd-and-dme-part-2 2023-11-06 0.50 https://www.ophthalmologytimes.com/view/learnings-from-real-world-evidence-of-faricimab-in-namd-and-dme-part-1 2023-11-06 0.50 https://www.ophthalmologytimes.com/view/aao-2023-ophthalmology-s-resilience-amid-physician-burnout-concerns 2023-10-30 0.50 https://www.ophthalmologytimes.com/view/aao-2023-suprachoroidal-outflow-enhancement-without-implantable-hardware-surgical-technique-and-clinical-results-of-a-novel-supraciliary-migs 2023-11-02 0.50 https://www.ophthalmologytimes.com/view/aao-2023-do-women-in-the-us-face-a-greater-burden-from-blindness-and-vision-loss- 2023-11-03 0.50 https://www.ophthalmologytimes.com/view/aao-2023-what-s-new-in-artificial-corneas-with-esen-k-akpek-md 2023-11-02 0.50 https://www.ophthalmologytimes.com/view/aao-2023-analysis-of-pegcetacoplan-for-cost-effective-treatment-of-geographic-atrophy 2023-11-03 0.50 https://www.ophthalmologytimes.com/view/aao-2023-escrs-brings-the-next-generation-of-ophthalmology-to-this-year-s-aao-meeting 2023-11-03 0.50 https://www.ophthalmologytimes.com/view/aao-2023-ocuterra-provides-update-on-phase-2-dr-eam-diabetic-retinopathy-study 2023-11-03 0.50 https://www.ophthalmologytimes.com/view/aao-2023-causes-and-care-of-paediatric-macular-holes 2023-11-10 0.50 https://www.ophthalmologytimes.com/view/looking-past-the-eye-in-paediatric-noninfectious-uveitis 2023-11-02 0.50 https://www.ophthalmologytimes.com/view/recap-the-latest-data-and-innovations-from-the-2023-euretina-congress 2023-11-02 0.50 https://www.ophthalmologytimes.com/view/machine-learning-a-view-from-new-angles 2023-11-02 0.50 https://www.ophthalmologytimes.com/view/aao-2023-phase-3-lynx-1-trial-data-show-phentolamine-ophthalmic-solution-improves-low-contrast-night-vision 2023-11-02 0.50 https://www.ophthalmologytimes.com/view/aao-2023-san-francisco-where-all-of-ophthalmology-meets- 2023-11-01 0.50 https://www.ophthalmologytimes.com/view/aao-2023-promising-outcomes-from-iol-implantation-following-radial-keratotomy 2023-11-01 0.50 https://www.ophthalmologytimes.com/view/espansione-group-shares-new-data-from-study-on-patients-with-surgery-induced-dry-eye 2023-10-31 0.50 https://www.ophthalmologytimes.com/view/setting-a-new-standard-in-automated-tracked-perimetry 2023-10-27 0.50 https://www.ophthalmologytimes.com/view/spectacle-independence-for-presbyopic-patients-achieving-success-and-satisfaction-with-zeiss-presbyond-even-in-a-highly-demanding-cohort 2025-06-05 0.50 https://www.ophthalmologytimes.com/view/presbyopia-correction-in-cataract-surgery-maximizing-success-and-satisfaction-with-the-new-at-elana-841p-iol 2023-11-16 0.50 https://www.ophthalmologytimes.com/view/fortified-antibiotic-advance-improves-corneal-infection-treatment-paradigm 2023-10-31 0.50 https://www.ophthalmologytimes.com/view/lensar-integrating-phacoemulsification-technology-from-oertli-instrumente-ag-into-adaptive-cataract-treatment-system 2023-10-30 0.50 https://www.ophthalmologytimes.com/view/aao-2023-ophthalmologists-must-see-the-museum-of-the-eye-in-san-francisco 2023-10-27 0.50 https://www.ophthalmologytimes.com/view/us-fda-approves-faricimab-svoa-for-the-treatment-of-retinal-vein-occlusion 2023-10-27 0.50 https://www.ophthalmologytimes.com/view/visgenx-issued-patent-for-compositions-of-elovl2-gene-therapy 2023-10-26 0.50 https://www.ophthalmologytimes.com/view/dry-eye-renaissance-escalating-cases-meet-with-innovation 2023-10-25 0.50 https://www.ophthalmologytimes.com/view/company-preview-upcoming-american-academy-of-ophthalmology-aao-2023-meeting-presentations-and-data-releases-in-san-francisco 2023-10-25 0.50 https://www.ophthalmologytimes.com/view/affamed-technologies-secures-exclusive-rights-for-revolutionary-evolux-iol-in-greater-china-market 2023-10-25 0.50 https://www.ophthalmologytimes.com/view/link-between-the-emc1-protein-and-retinal-vascular-development-uncovered 2023-10-19 0.50 https://www.ophthalmologytimes.com/view/the-cost-of-the-h-index 2023-11-10 0.50 https://www.ophthalmologytimes.com/view/samsung-bioepis-presented-a-post-hoc-analysis-of-the-phase-3-clinical-study-results-for-sb15-at-euretina-2023 2023-10-18 0.50 https://www.ophthalmologytimes.com/view/aao-returns-to-san-francisco-for-annual-meeting-this-november 2023-10-16 0.50 https://www.ophthalmologytimes.com/view/cerebral-visual-impairment-documenting-visual-effects-and-simplifying-visual-life 2023-11-10 0.50 https://www.ophthalmologytimes.com/view/the-oral-therapeutic-that-could-change-our-approach-to-retinal-disease 2023-10-12 0.50 https://www.ophthalmologytimes.com/view/hcp-cureblindness-brings-focus-to-avoidable-vision-loss-for-world-sight-day 2023-10-13 0.50 https://www.ophthalmologytimes.com/view/in-home-accustat-vision-test-equivalent-results-to-in-office-snellen-measurements 2023-10-10 0.50 https://www.ophthalmologytimes.com/view/espansione-group-shares-preliminary-results-from-lightwave-i-a-multicentric-randomized-controlled-investigation-of-lm-lllt-technology-for-dry-amd 2023-10-10 0.50 https://www.ophthalmologytimes.com/view/potential-bacterial-involvement-in-the-development-of-severe-rop 2023-10-09 0.50 https://www.ophthalmologytimes.com/view/euretina-2023-emerging-therapies-for-exudative-amd 2023-10-09 0.50 https://www.ophthalmologytimes.com/view/arctic-vision-completes-enrollment-in-phase-3-trial-for-uveitic-macular-oedema-treatment-arcatus 2023-10-05 0.50 https://www.ophthalmologytimes.com/view/lead-study-reducing-amd-progression-rates-with-subthresold-nanosecond-laser-in-eyes-with-no-pseudo-drusen 2024-01-30 0.50 https://www.ophthalmologytimes.com/view/euretina-2023-safety-and-efficacy-through-week-48-in-the-phase-2a-starlight-clinical-trial 2023-10-03 0.50 https://www.ophthalmologytimes.com/view/euretina-2023-dr-ali-erginay-discusses-advancements-in-ultra-widefield-imaging 2023-10-02 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-networking-highlights-from-this-year-s-congress-in-vienna-austria 2023-10-05 0.50 https://www.ophthalmologytimes.com/view/euretina-2023-the-real-world-efficacy-and-safety-of-faricimab-in-neovascular-amd-the-truckee-study 2023-10-03 0.50 https://www.ophthalmologytimes.com/view/euretina-2023-dr-varun-chaudhary-discusses-posturing-after-macular-hole-surgery 2023-09-28 0.50 https://www.ophthalmologytimes.com/view/inherited-retinal-diseases-and-gene-therapies-a-pharmaceutical-overview 2023-10-04 0.50 https://www.ophthalmologytimes.com/view/bausch-lomb-announces-launch-of-pure-line-gases-for-retina-surgeons-ahead-of-euretina-annual-meeting 2023-10-04 0.50 https://www.ophthalmologytimes.com/view/dynamic-range-of-focus-recovery-in-presbyopes-after-laser-scleral-microporation 2023-10-03 0.50 https://www.ophthalmologytimes.com/view/paul-implant-good-iop-lowering-fewer-complications-compared-with-baerveldt-device 2023-11-10 0.50 https://www.ophthalmologytimes.com/view/gonioscopy-assisted-transluminal-trabeculotomy-gatt-offers-relief-for-patients-undergoing-corneal-transplant 2023-10-02 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-attendee-highlights-from-the-arena-to-the-exhibit-hall 2023-09-29 0.50 https://www.ophthalmologytimes.com/view/impact-of-disease-activity-criteria-on-dosing-interval-assignment-in-clinical-trials-in-namd 2023-09-28 0.50 https://www.ophthalmologytimes.com/view/treating-anisometropic-amblyopia-with-a-dichoptic-digital-platform-paediatric 2023-11-10 0.50 https://www.ophthalmologytimes.com/view/distorted-corneas-how-to-regularise-them-with-minimally-invasive-surgery 2023-10-02 0.50 https://www.ophthalmologytimes.com/view/us-fda-approves-ryzumvi-phentolamine-ophthalmic-solution-for-the-treatment-of-pharmacologically-induced-mydriasis 2023-09-27 0.50 https://www.ophthalmologytimes.com/view/industry-sponsored-satellite-symposia-at-the-23rd-euretina-congress 2023-09-26 0.50 https://www.ophthalmologytimes.com/view/23rd-annual-euretina-congress-seeing-eye-to-eye-in-amsterdam-retina-meeting 2023-09-25 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-olivier-benoit-says-ciliatech-s-glaucoma-implant-defied-his-expectations 2023-09-22 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-talking-next-generation-femtosecond-lasers-for-corneal-surgery-with-dr-rohit-shetty 2023-09-25 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-ana-neves-cataract-refractive-laser-cornea-workflow-oriented-zeiss-booth 2023-09-22 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-dr-amir-hamid-technology-femtosecond-laser-iol-workflow 2023-09-21 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-fritz-hengerer-md-phd-presents-new-data-for-cataract-surgeons 2023-09-21 0.50 https://www.ophthalmologytimes.com/view/study-children-vision-impairment-reduced-quality-of-life-orbis-international-research 2023-09-19 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-glaucoma-migs-research-dr-sheng-lim 2023-09-18 0.50 https://www.ophthalmologytimes.com/view/intravitreal-stem-cell-therapy-protection-degenerations-eye 2023-09-18 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-new-artificial-intelligence-integrations-are-ahead-for-icare 2023-09-18 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-scott-d-barnes-md-looks-to-the-future-of-user-friendly-lens-injectors 2023-09-14 0.50 https://www.ophthalmologytimes.com/view/retfound-artificial-intelligence-model-to-detect-retinal-disease-biomarkers-developed-by-moorfields-eye-hospital 2023-09-14 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-device-phaco-drives-rebrand-tools-geuder 2023-09-14 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-data-itrack-canaloplasty-registry-glaucoma-surgery-nova-keith-barton 2023-09-14 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-orbis-international-education-partnership-celebrates-20-years-of-cybersight 2023-09-13 0.50 https://www.ophthalmologytimes.com/view/study-mercury-3-trial-results-support-efficacy-roclanda-iop-glaucoma 2023-09-13 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-managing-directors-heidelberg-engineering-orbis-partnersship-schoess-vargas-vadhia 2023-09-12 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-greg-kunst-aurion-biotech-cornea-cell-therapies 2023-09-12 0.50 https://www.ophthalmologytimes.com/view/syncona-novartis-discontinue-development-of-gt005-for-geographic-atrophy-gyroscope-amd 2023-09-12 0.50 https://www.ophthalmologytimes.com/view/bausch-lomb-launches-miebo-perfluorohexyloctane-ophthalmic-solution-in-us 2023-09-12 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-presbyopia-treatment-with-microperation-therapeutic-technology-by-ace-vision-group 2023-09-12 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-thomas-bosshard-oertli-3-platform-approach-cataract-instrument-device 2023-09-11 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-krysten-williams-heidelberg-image-quality-into-the-surgical-operating-room 2023-09-09 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-ace-vision-group-presents-scientific-data-focused-on-laser-scleral-microporation 2023-09-09 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-binkhorst-medal-lecture-addresses-the-future-of-cataract-and-refractive-surgery 2023-09-09 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-integrated-workflow-solutions-in-cataract-procedures 2023-09-08 0.50 https://www.ophthalmologytimes.com/view/escrs-2023-owl-brings-more-of-the-world-to-ophthalmic-world-leaders 2023-09-08 0.50 https://www.ophthalmologytimes.com/view/orbis-and-heidelberg-engineering-announce-new-partnership-at-escrs-congress 2023-09-08 0.50 https://www.ophthalmologytimes.com/view/ciliatech-presents-clinical-trial-results-from-safari-iii-glaucoma-study 2023-09-07 0.50 https://www.ophthalmologytimes.com/view/impact-of-personalised-faricimab-dosing-in-neovascular-amd-clinical-trial-outcomes 2023-09-06 0.50 https://www.ophthalmologytimes.com/view/ophthalmology-end-of-lasik-lenticule-extraction-obsolete 2023-09-06 0.50 https://www.ophthalmologytimes.com/view/bvi-acquires-medical-mix-expanding-its-presence-in-europe-spain-portugal 2023-09-06 0.50 https://www.ophthalmologytimes.com/view/artificial-intelligence-early-detection-ectatic-corneal-diseases-diagnosis-algorithm 2023-09-05 0.50 https://www.ophthalmologytimes.com/view/asrs-retina-specialists-2023-which-topics-at-the-annual-meeting-did-researchers-find-exciting- 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-presenters-share-fascinating-research-highlights-from-the-2023-asrs-annual-meeting 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-what-research-is-most-exciting-attendees-opinion-bonus 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/corneal-refractive-surgery-for-presbyopia-why-zeiss-presbyond-was-our-preferred-solution 2025-06-05 0.50 https://www.ophthalmologytimes.com/view/zeiss-medical-technology-previews-refractive-workflow-innovations-ahead-of-escrs-annual-meeting 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/wio-2023-dr-maria-h-berrocal-on-robots-3d-surgery-and-the-future-of-surgical-retina 2023-08-30 0.50 https://www.ophthalmologytimes.com/view/johnson-johnson-vision-launch-elita-platform-laser-escrs-2023 2023-08-30 0.50 https://www.ophthalmologytimes.com/view/escrs-dual-milestones-eurequo-registry-4-million-15-years-meeting-refractive-cataract-surgery 2023-08-30 0.50 https://www.ophthalmologytimes.com/view/breaking-news-us-fda-issues-crl-outlook-therapeutics-ons-5010 2023-08-30 0.50 https://www.ophthalmologytimes.com/view/wio-2023-icl-clear-lens-exchange-refractive-surgery 2023-08-29 0.50 https://www.ophthalmologytimes.com/view/atsena-therapeutics-patient-phase-i-ii-clinical-trial-atsn-201-treatment-x-linked-retinoschisis 2023-08-28 0.50 https://www.ophthalmologytimes.com/view/imaging-trends-in-paediatric-uveitis 2023-08-28 0.50 https://www.ophthalmologytimes.com/view/immunosuppressants-control-ocular-inflammation-not-involved-cancer-development 2023-08-25 0.50 https://www.ophthalmologytimes.com/view/cutting-edge-advances-corneal-treatment 2023-08-24 0.50 https://www.ophthalmologytimes.com/view/kiora-pharmaceuticals-european-us-patents-local-ocular-delivery-kio-100-compounds 2023-08-23 0.50 https://www.ophthalmologytimes.com/view/lenticule-extraction-hyperopia-update-comparable-lasik 2023-08-22 0.50 https://www.ophthalmologytimes.com/view/ema-approves-clinical-trial-application-retinitis-pigmentosa-therapy-from-vigeneron 2023-08-22 0.50 https://www.ophthalmologytimes.com/view/retina-biomarkers-before-clinical-diagnosis-parkinson-disease 2023-08-22 0.50 https://www.ophthalmologytimes.com/view/macular-retinal-detachment-development-associated-myopic-foveoschisis 2023-08-18 0.50 https://www.ophthalmologytimes.com/view/us-fda-approves-regeneron-s-aflibercept-injection-8mg-for-treatment-of-dme-dr-wet-amd 2023-08-19 0.50 https://www.ophthalmologytimes.com/view/ema-accepts-iveric-bio-s-avacincaptad-pegol-acp-for-maa-review 2023-08-18 0.50 https://www.ophthalmologytimes.com/view/recap-european-society-ophthalmology-prague-focal-point-eye-care-soe 2023-08-16 0.50 https://www.ophthalmologytimes.com/view/better-iol-calculation-in-post-lasik-eyes 2023-08-15 0.50 https://www.ophthalmologytimes.com/view/sandoz-positive-results-biosimilar-aflibercept-mylight-phase-iii-study 2023-08-15 0.50 https://www.ophthalmologytimes.com/view/surgical-management-of-posterior-uveitis-in-children 2023-08-11 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-megan-baldwin-ceo-opthea-limited-sozinibercept 2023-08-10 0.50 https://www.ophthalmologytimes.com/view/euclid-vision-founder-george-glady-passes-away-at-73-obituary-death 2023-08-10 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-nancy-lurker-eyepoint-pharmaceuticals-update-phase-1-davio-trial-eyp-1901 2023-08-09 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-insights-on-fluid-control-with-faricimab-compared-to-aflibercept-in-recent-studies-with-aleksandra-rachiskaya-md 2023-08-09 0.50 https://www.ophthalmologytimes.com/view/new-glaucoma-treatment-development-cilioscleral-technique-ciliatech 2023-08-22 0.50 https://www.ophthalmologytimes.com/view/extended-dosing-faricimab-greater-fluid-control-compared-aflibercept-dme 2023-08-07 0.50 https://www.ophthalmologytimes.com/view/shedding-light-importance-autophagy-amd 2023-11-10 0.50 https://www.ophthalmologytimes.com/view/fda-approval-iveric-bio-avacincaptad-pegol-intravitreal-solution-treatment-geographic-atrophy 2023-08-18 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-ursula-schmidt-erfurth-md-gale-extension-study 2023-08-03 0.50 https://www.ophthalmologytimes.com/view/preview-escrs-congress-2023-vienna-austria-cataract-refractive-surgery 2023-08-03 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-insights-faretina-study-diabetic-macular-oedema-durga-borkar 2023-08-02 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-fernando-arevalo-retinal-detachments-retinoschisis 2023-08-02 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-dante-pieramici-md-update-opt-302-sozinibercept 2023-08-01 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-27-gauge-vs-25-gauge-vitrectomy-for-symptomatic-vitreous-opacities 2023-08-01 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-michael-ip-md-key-trends-perspectives-2023-meeting-seattle 2023-07-31 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-data-photon-study-8-milligrams-aflibercept-diabetic-macular-oedema-dme 2023-07-31 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-intended-versus-actual-treatment-intervals-between-intravitreal-anti-vegf-injections-effects-treatment-delays 2023-07-28 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-results-gather-clinical-trials-carl-danzig 2023-07-31 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-aaron-lee-deep-learning-models-ophthalmology 2023-07-31 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-macgyver-endolaser-option-chandelier-assisted-scleral-buckles 2023-07-28 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-health-disparities-lapses-diabetic-retinopathy-care 2023-07-28 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-efficacy-safety-biosimilars-ranibizumab-nuna-ranibizumab-eqrn-in-clinical-use 2023-07-28 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-outcomes-clinical-features-predictive-fungal-endophthalmitis 2023-07-31 0.50 https://www.ophthalmologytimes.com/view/normalised-blood-flow-biomarker-detect-diabetic-retinopathy 2023-07-24 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-detection-early-diabetic-retinopathy-oct-a-bloodflow 2023-07-28 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-improving-vision-dry-amd-mechanism-disease-stage 2023-07-28 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-annexon-results-archer-phase-2-trial-treatment-geographic-atrophy 2023-07-27 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-ocuphire-to-present-data-evaluating-apx3330-in-diabetic-retinopathy 2023-07-27 0.50 https://www.ophthalmologytimes.com/view/oct-valuable-detecting-macular-pathologies-patients-scleritis 2023-07-27 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-new-clinical-and-real-world-data-for-faricimab-reveal-improved-outcomes-for-patients-diagnosed-with-dme-namd 2023-07-27 0.50 https://www.ophthalmologytimes.com/view/breaking-news-fda-approves-xdemvy-treatment-demodex-blepharitis 2023-07-25 0.50 https://www.ophthalmologytimes.com/view/chmp-european-positive-opinion-aflibercept-biosimilar-yesafili 2023-07-28 0.50 https://www.ophthalmologytimes.com/view/women-leaders-better-global-health-outcomes 2023-07-21 0.50 https://www.ophthalmologytimes.com/view/key-retreatment-decisions-in-the-clinical-trials-for-faricimab-in-namd 2023-07-21 0.50 https://www.ophthalmologytimes.com/view/impact-of-personalized-dosing-of-faricimab-on-treatment-outcomes-in-namd 2023-07-21 0.50 https://www.ophthalmologytimes.com/view/aviceda-therapeutics-avd-104-asrs-2023-ois 2023-07-21 0.50 https://www.ophthalmologytimes.com/view/opthea-opt-302-oral-presentation-asrs-2023 2023-07-19 0.50 https://www.ophthalmologytimes.com/view/sequential-bilateral-cataract-surgeries-safe-viable-protocol-decrease-elective-volume 2023-07-19 0.50 https://www.ophthalmologytimes.com/view/corneal-cross-linking-keratoconus-relapse-penetrating-keratoplasty 2023-07-17 0.50 https://www.ophthalmologytimes.com/view/low-dose-atropine-drops-ineffective-stopping-myopia-progression-children 2023-07-14 0.50 https://www.ophthalmologytimes.com/view/new-drug-application-australia-therapeutic-goods-administration-treatment-uveitic-macular-edema 2023-07-13 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-view-seattle-scene 2023-07-13 0.50 https://www.ophthalmologytimes.com/view/asrs-2023-meeting-retina-science-innovation-seattle 2023-07-13 0.50 https://www.ophthalmologytimes.com/view/tenpoint-therapeutics-cell-therapy-launch-funding 2023-07-12 0.50 https://www.ophthalmologytimes.com/view/screening-diabetic-retinopathy-imaging-artificial-intelligence-smartphone 2023-07-12 0.50 https://www.ophthalmologytimes.com/view/global-study-genetic-targets-glaucoma-risk 2023-07-10 0.50 https://www.ophthalmologytimes.com/view/topical-insulin-drops-refractory-corneal-epithelial-defect-treatment 2023-07-10 0.50 https://www.ophthalmologytimes.com/view/visual-neovascular-amd-vegf-therapy-macular-thickness 2023-07-10 0.50 https://www.ophthalmologytimes.com/view/belite-bio-phoenix-clinical-trial-phase-taiwan 2023-07-07 0.50 https://www.ophthalmologytimes.com/view/simulations-telementoring-orbis-international-training-cataract-surgery 2023-07-07 0.50 https://www.ophthalmologytimes.com/view/international-glaucoma-surgical-registry-elios-vision-partnership 2023-07-05 0.50 https://www.ophthalmologytimes.com/view/eyecare-partners-ophthalmology-fellowship-applications-open 2023-06-29 0.50 https://www.ophthalmologytimes.com/view/bausch-lomb-acquisition-xiidra-novartis-dry-eye 2023-06-30 0.50 https://www.ophthalmologytimes.com/view/ciliatech-data-implant-world-glaucoma-congress 2023-06-29 0.50 https://www.ophthalmologytimes.com/view/midface-surgery-ocular-outcomes-orbital-midface-malformations 2023-07-07 0.50 https://www.ophthalmologytimes.com/view/novel-therapies-in-neovascular-amd-and-dme-achieving-superior-anatomic-outcomes-with-fewer-injections 2023-06-29 0.50 https://www.ophthalmologytimes.com/view/elios-vision-enrollment-microinvasive-glaucoma-surgery-trial-clinical 2023-06-28 0.50 https://www.ophthalmologytimes.com/view/santen-data-preserflo-microshunt-endothelial-cell-density-loss 2023-06-28 0.50 https://www.ophthalmologytimes.com/view/tepezza-approved-ted-treatment-brazil 2023-06-27 0.50 https://www.ophthalmologytimes.com/view/fda-issues-crl-aflibercept-regeneron-pharmaceuticals 2023-06-28 0.50 https://www.ophthalmologytimes.com/view/oculis-retina-day-showcase-global-event-clinical-programs 2023-06-28 0.50 https://www.ophthalmologytimes.com/view/retinal-imaging-predict-cerebrovascular-diseases 2023-06-23 0.50 https://www.ophthalmologytimes.com/view/optogenetics-research-prize-neuroscience-retina-vision-international 2023-06-22 0.50 https://www.ophthalmologytimes.com/view/patient-cases-demonstrating-the-application-of-treat-and-extend-algorithm-for-faricimab-in-dme 2023-06-22 0.50 https://www.ophthalmologytimes.com/view/visual-and-anatomic-outcomes-with-faricimab-in-dme-using-the-treat-and-extend-algorithm 2023-06-22 0.50 https://www.ophthalmologytimes.com/view/australian-study-cost-ird-genetic-eye-disease-million-patient 2023-06-21 0.50 https://www.ophthalmologytimes.com/view/allgenesis-phase-1b-data-improvement-dry-eye-patients 2023-06-20 0.50 https://www.ophthalmologytimes.com/view/rodenstock-myopia-control-corrective-spectacle-lenses-children 2023-06-19 0.50 https://www.ophthalmologytimes.com/view/video-recap-european-society-ophthalmology-soe-2023 2023-06-16 0.50 https://www.ophthalmologytimes.com/view/soe-2023-antimicrobial-resistance-challenge-innovations 2023-06-15 0.50 https://www.ophthalmologytimes.com/view/soe-2023-ai-eye-care-japan-emerging-challenges 2023-06-15 0.50 https://www.ophthalmologytimes.com/view/soe-2023-new-surgeries-glaucoma-market 2023-06-16 0.50 https://www.ophthalmologytimes.com/view/soe-2023-a-look-at-current-treatment-options-for-diabetic-macular-oedema 2023-06-13 0.50 https://www.ophthalmologytimes.com/view/soe-2023-treatment-options-diabetic-macular-edema 2023-06-15 0.50 https://www.ophthalmologytimes.com/view/soe-2023-cataract-surgery-opaque-cornea 2023-06-15 0.50 https://www.ophthalmologytimes.com/view/soe-2023-optic-neuropathy-versus-maculopathy 2023-06-16 0.50 https://www.ophthalmologytimes.com/view/soe-2023-mixed-method-study-geographic-atrophy 2023-06-16 0.50 https://www.ophthalmologytimes.com/view/soe-2023-maculopathy-excessive-caffeine-alcohol-intake 2023-06-14 0.50 https://www.ophthalmologytimes.com/view/soe-2023-dehydrated-human-amniotic-membrane-ocular-surface 2023-06-14 0.50 https://www.ophthalmologytimes.com/view/truckee-study-faricimab-neovascular-results 2023-06-09 0.50 https://www.ophthalmologytimes.com/view/early-test-research-diabetic-peripheral-neuropathy 2023-06-15 0.50 https://www.ophthalmologytimes.com/view/syncona-ophthalmic-gene-therapy-beacon-therapeutics 2023-06-12 0.50 https://www.ophthalmologytimes.com/view/escrs-virtual-learning-cme-accredited 2023-06-12 0.50 https://www.ophthalmologytimes.com/view/oxurion-belgium-kalahari-trial-diabetic-macular-edema 2023-06-12 0.50 https://www.ophthalmologytimes.com/view/bns-ophthalmic-nanotechnology-pharmaceutical-products 2023-06-09 0.50 https://www.ophthalmologytimes.com/view/extended-depth-focus-intraocular-lens-cataract 2023-06-01 0.50 https://www.ophthalmologytimes.com/view/achieving-spectacle-independence-with-presbyond-laser-blended-vision 2025-08-13 0.50 https://www.ophthalmologytimes.com/view/laser-trabeculoplasty-glaucoma-treatment-poag 2023-06-07 0.50 https://www.ophthalmologytimes.com/view/european-society-ophthalmology-soe-focus-young-career 2023-06-07 0.50 https://www.ophthalmologytimes.com/view/glaucoma-interventional-cataract-refractive-surgeons 2023-06-01 0.50 https://www.ophthalmologytimes.com/view/european-society-ophthalmology-2023-soe-congress 2023-06-07 0.50 https://www.ophthalmologytimes.com/view/new-nhs-testing-access-england-eye-care 2023-06-02 0.50 https://www.ophthalmologytimes.com/view/pseudomonas-scleritis-management-surgery-infection 2023-06-09 0.50 https://www.ophthalmologytimes.com/view/companies-investment-regulation-benefits-biotech-switzerland 2023-05-31 0.50 https://www.ophthalmologytimes.com/view/a-closer-look-at-how-cell-therapy-for-corneal-endothelial-disease-is-gaining-traction 2023-05-26 0.50 https://www.ophthalmologytimes.com/view/upgrading-cataract-surgery-skills-unlocking-the-full-potential-of-surgical-video-review-using-an-ai-based-application 2025-06-05 0.50 https://www.ophthalmologytimes.com/view/icare-home-tonometers-optimize-patient-care 2023-05-26 0.50 https://www.ophthalmologytimes.com/view/preservative-free-latanoprost-bak-glaucoma-ocular-hypertension 2023-05-31 0.50 https://www.ophthalmologytimes.com/view/paediatric-glaucoma-diagnosis-exam-treatment 2023-11-10 0.50 https://www.ophthalmologytimes.com/view/united-kingdom-ophthalmologist-certification-sight-impaired-benefits 2023-05-25 0.50 https://www.ophthalmologytimes.com/view/spring-summer-heatwave-ophthalmology-eye-vision-risk 2023-05-24 0.50 https://www.ophthalmologytimes.com/view/combination-myopia-management-treatments-atropine-orthokeratology 2023-05-24 0.50 https://www.ophthalmologytimes.com/view/trachoma-blindness-public-health-endemic-who 2023-05-24 0.50 https://www.ophthalmologytimes.com/view/alvotech-polifarma-eylea-turkey-aflibercept-vegf 2023-05-22 0.50 https://www.ophthalmologytimes.com/view/medical-student-clinical-education-learning-outcome 2023-05-22 0.50 https://www.ophthalmologytimes.com/view/childhood-pre-myopia-control-prevention-axial-length 2023-05-19 0.50 https://www.ophthalmologytimes.com/view/breaking-news-fda-approves-perfluorohexyloctane-ophthalmic-solution-for-dry-eye-disease 2023-05-18 0.50 https://www.ophthalmologytimes.com/view/trending-increasing-incidence-of-eye-injuries-in-children-caused-by-toys 2023-05-16 0.50 https://www.ophthalmologytimes.com/view/providing-spectacle-independence-for-a-young-adult-patient-with-cataract-and-astigmatism 2025-08-13 0.50 https://www.ophthalmologytimes.com/view/lazrplastique-technique-provides-a-non-cutting-edge-over-lasik 2023-05-12 0.50 https://www.ophthalmologytimes.com/view/tracking-the-trends-in-incisional-glaucoma-surgery-patterns 2023-05-10 0.50 https://www.ophthalmologytimes.com/view/fda-approves-eyenovia-s-ophthalmic-spray-for-mydriasis 2023-05-09 0.50 https://www.ophthalmologytimes.com/view/orbis-brings-school-based-eye-health-intervention-to-children-in-india 2023-04-29 0.50 https://www.ophthalmologytimes.com/view/restoring-vision-through-retinal-ganglion-cell-repopulation 2023-04-28 0.50 https://www.ophthalmologytimes.com/view/on-the-horizon-treatments-for-both-forms-of-amd 2023-04-28 0.50 https://www.ophthalmologytimes.com/view/smile-for-myopia-and-myopic-astigmatism-increasing-procedural-ease-and-efficiency-with-the-visumax-800-femtosecond-laser 2025-06-05 0.50 https://www.ophthalmologytimes.com/view/what-innovation-means-for-the-treatment-of-corneal-dystrophies 2023-04-28 0.50 https://www.ophthalmologytimes.com/view/cosmetic-surgery-of-the-cornea-a-new-type-of-surgery 2023-04-28 0.50 https://www.ophthalmologytimes.com/view/arvo-2023-lamina-cribrosa-pressure-and-predicting-structural-glaucoma-progression 2023-04-26 0.50